Lie Ming Ding
Chief Executive Officer at BETTA PHARMACEUTICALS CO., LTD.
Net worth: 60 M $ as of 31/03/2024
Profile
Founder of Betta Pharmaceuticals Co., Ltd., Lie Ming Ding currently is Chairman, Co-Chief Executive Officer & GM at Betta Pharmaceuticals Co., Ltd. and General Manager & Executive Director at Ningbo Kaiming Venture Technology Co., Ltd., Chairman & General Manager at Zhejiang Betta Pharmaceuticals Co., Ltd. (a subsidiary of Ningbo Kaiming Venture Technology Co., Ltd.). Dr. Ding is also on the board of Betta Investment (Hong Kong) Ltd. In the past he was Senior Research Associate-Cancer Institute at The University of Arkansas. Lie Ming Ding received a doctorate from The University of Arkansas.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2023 | 9,924,563 ( 2.40% ) | 56 M $ | 31/03/2024 | |
| 30/09/2023 | 739,978 ( 56.97% ) | 4 M $ | 31/03/2024 |
Lie Ming Ding active positions
| Companies | Position | Start |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Chief Executive Officer | 23/08/2013 |
Betta Investment (Hong Kong) Ltd.
 Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Director/Board Member | - |
Zhejiang Betta Pharmaceuticals Co., Ltd.
 Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Chief Executive Officer | - |
Ningbo Kaiming Venture Technology Co., Ltd.
 Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Chief Executive Officer | - |
Wuhan Healthgen Biotechnology Corp.
 Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Director/Board Member | 20/06/2022 |
Former positions of Lie Ming Ding
| Companies | Position | End |
|---|---|---|
| The University of Arkansas | Corporate Officer/Principal | - |
Training of Lie Ming Ding
| The University of Arkansas | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
| Private companies | 4 |
|---|---|
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Health Technology |
Betta Investment (Hong Kong) Ltd.
Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Finance |
Zhejiang Betta Pharmaceuticals Co., Ltd.
Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Commercial Services |
Ningbo Kaiming Venture Technology Co., Ltd.
Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Technology Services |
- Stock Market
- Insiders
- Lie Ming Ding
